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Background: Cardiac nestin(+) cells exhibit properties of a neural progenitor/stem cell population characterized by
the de novo synthesis of neurofilament-M in response to ischemic injury and 6-hydroxydopamine administration.
The induction of growth associated protein 43 (GAP43) was identified as an early event of neurogenesis. The
present study tested the hypothesis that the de novo synthesis of neurofilament-M by nestin(+) cells was preceded
by the transient upregulation of GAP43 during the acute phase of reparative fibrosis in the infarcted male rat heart.
Secondly, a seminal feature of diabetes is impaired wound healing secondary to an inadequate neurogenic
response. In this regard, an additional series of experiments tested the hypothesis that the neurogenic response of
cardiac nestin(+) cells was attenuated in a setting of type I diabetes.
Methods: The neurogenic response of cardiac nestin(+) cells was examined during the early phase of reparative
fibrosis following permanent ligation of the left anterior descending coronary artery in the adult male rat heart. The
experimental model of type I diabetes was created following a single injection of streptozotocin in adult male rats.
The impact of a type I diabetic environment on the neurogenic response of cardiac nestin(+) cells was examined
during myocardial infarction and following the administration of 6-hydroxydopamine.
Results: During the early phase of scar formation/healing, the density of GAP43/nestin(+) fibres innervating the
peri-infarct/infarct region was significantly increased, whereas neurofilament-M/nestin(+) fibres were absent. With
ongoing scar formation/healing, a temporal decrease of GAP43/nestin(+) fibre density and a concomitant increase
in the density of innervating neurofilament-M/nestin(+) fibres were observed. The neurogenic response of cardiac
nestin(+) cells during scar formation/healing was inhibited following the superimposition of type I diabetes. The
de novo synthesis of neurofilament-M by nestin(+) cells after 6-hydroxydopamine administration was likewise
attenuated in the heart of type I diabetic rats whereas the density of GAP43/nestin(+) fibres remained elevated.
Conclusion: The transient upregulation of GAP43 apparently represents a transition event during the acquisition
of a neuronal-like phenotype and a type I diabetic environment attenuated the neurogenic response of cardiac
nestin(+) cells to ischemia and 6-hydroxydopamine.
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and peri-infarct/infarct region represents a seminal fea-
ture of myocardial infarction [1-4]. Sympathetic fibres
innervating the non-infarcted myocardium provide ino-
tropic support to the ischemically damaged heart and
contribute to the hypertrophic response [5,6]. During
the reparative fibrotic response, innervating sympathetic
fibres may directly contribute to scar formation/healing
via the release of norepinephrine and subsequent stimu-
lation of myofibroblast growth [7,8]. However, neural
remodelling of the peri-infarct/infarct region was not
limited to sympathetic fibre hyperinnervation as work
from our lab reported the appearance of neuronal-like
fibres originating from cardiac resident nestin(+) cells [9,10].
The normal rodent heart contains a population of nestin(+)
cells that exhibit properties of a neural progenitor/stem cell
[11-15]. In vitro experiments revealed that a subpopulation
of cardiac resident nestin(+) cells differentiated to a neuronal
phenotype when plated in the appropriate induction milieu
characterized by the upregulation of neurofilament-M and
beta III-tubulin [12]. The in vitro response was recapitu-
lated in vivo as the de novo synthesis of neurofilament-M
by a subpopulation of cardiac resident nestin(+) cells
was observed during the reparative fibrotic response
of the ischemically damaged rat heart and after 6-
hydroxydopamine administration [9,10,12]. The induc-
tion of growth associated protein 43 (GAP43) was
identified as an early event of neurogenesis in develop-
ment and learning and increased expression was reported
during the regeneration of injured peripheral nerves [16-19].
In vitro studies further revealed that the transition of skin-
derived cells from a proliferative precursor to a neuronal
phenotype was associated with the downregulation of nestin
and concomitant expression of GAP43 [13]. Despite these
findings, the expression and temporal regulation of GAP43
during neural progenitor/stem cell transition to a neuronal
phenotype in a setting of wound healing remains un-
examined. Therefore, the present study tested the hypoth-
esis that the de novo synthesis of neurofilament-M by a
subpopulation of cardiac resident nestin(+) cells during
the early phase of reparative fibrosis was preceded by
the transient upregulation of GAP43.
It has been well established that diabetic patients have
a higher mortality rate following acute myocardial in-
farction as compared to non-diabetic patients [20,21]. The
latter paradigm was recapitulated experimentally as Luo
and colleagues reported that the superimposition of myo-
cardial infarction on type I diabetic mice led to 70-80%
mortality 3–4 days following complete coronary artery
ligation and was 2-fold higher than non-diabetic myocar-
dial infarcted mice [22]. A pathological feature of diabetes
that may contribute to the reported increase in mortality
is impaired wound healing secondary to an inadequate
neurogenic response [23-26]. The inadequate neurogenicresponse reported in diabetic injured tissue may be related
in part to the suppression of neural/progenitor stem cell
differentiation to a neuronal phenotype. In this regard, a
second series of experiments tested the hypothesis that
the transition of cardiac resident nestin(+) cells to a
neuronal-like phenotype in the ischemically damaged
rat heart and after 6-hydroxydopamine administration
was suppressed in a type 1 diabetic environment.
Methods
Myocardial infarction and type I diabetes
Myocardial infarction (MI) in adult male Sprague–Dawley
rats (9–11 weeks old; Charles Rivers, Canada) was created
by permanently ligating the left anterior descending cor-
onary artery [10]. Sham animals underwent the identical
surgical procedure except the coronary artery was not li-
gated. Experimental model of type I diabetes was induced
following a single intraperitoneal injection of streptozotocin
(60 mg/kg) in adult male Sprague–Dawley rats (9–11 weeks
old; Charles Rivers, Canada) [27]. In a first study, adult
rats were injected with streptozotocin and 1 week later
subjected to permanent coronary artery ligation. This
study was halted because of the high mortality rate of
diabetic rats following surgery (please see Results sec-
tion). An alternative approach was employed as a proof
of concept and 3-day post-MI rats were injected with
streptozotocin and sacrificed 7 days later. In this study,
all diabetic post-MI rats survived the protocol. In paral-
lel, post-MI rats were sacrificed 10 days after surgery.
Lastly, seven days after the injection of adult male
Sprague–Dawley with streptozotocin, type I diabetic rats
(n = 5) were administered 6-hydroxydopamine hydrobromide
(Sigma-Aldrich; IV injection of 100 mg/kg/day for 3 days)
and sacrificed 2 days after completion of treatment
[9,12]. In parallel, sham rats (n = 4) were administered
6-hydroxydopamine as described above and sacrificed
2 days after last injection. Plasma glucose levels were
measured with a glucometer (Bayer; Model Ascensia
Elite XL) from blood samples obtained from the tail
vein. Left ventricular function was measured with a
microtip pressure transducer catheter (model SPR-407,
2 F, Millar instrument, Houston Texas) and data ana-
lyzed with the program IOX version 1.8.9 (Emka Tech-
nologies; Falls Church, VA) [9]. At the end of each
experiment, the heart was removed, weighed and stored
in 2-methylbutane for immunofluorescence or separated
into the left ventricle, right ventricle and scar, weighed,
stored at −80°C and subsequently used for protein ana-
lysis. To determine scar area, the infarct region was
traced, the outlined region visualized with the Olympus
SZX7 microscope (Tokyo, Japan) and the area measured
with data acquisition program Stream Basic (Olympus).
The use and care of laboratory rats was according to
the Canadian Council for Animal Care and approved by
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Western blot
Protein lysates prepared from the left ventricle of normal
and diabetic rats and non-infarcted left ventricle and
scar of non-diabetic and diabetic infarcted rats were
subjected to SDS-electrophoresis, as previously described
[27]. Antibodies used include the mouse monoclonal
anti-nestin (1:500; Chemicon, Temicula, CA), the rabbit
polyclonal GAP43 (1:500; Abcam, Cambridge, MA) and
the mouse monoclonal anti-GAPDH (1:50,000; Ambion,
Austin TX). Following overnight incubation at 4°C, the
appropriate secondary antibody-conjugated to horse-
radish peroxidase (1:20,000, Jackson Immunoresearch,
West Grove, PA) was added and bands visualized util-
izing the ECL detection kit (Perkin Elmer). Films were
scanned with Image J software® and the target protein
signal was depicted as arbitrary light units normalized
to GAPDH protein content.
Immunofluorescence
The heart was excised, immersed directly in 2-methylbutane
(temperature maintained at −80°C), and stored at −80°C.
Immunofluorescence on cardiac tissue (cryostat sections
of 14 μm thickness) was performed as previously de-
scribed [9,27]. Antibodies employed include the mouse
monoclonal anti-nestin (1:500; Chemicon), rabbit poly-
clonal anti-GAP43 (1:150; Abcam) and rabbit polyclonal
anti-neurofilament-M (1:500; Chemicon). The nucleus
was identified with TO-PRO-3 (InVitrogen; 1.5 μM;
emission wavelength, 661 nm) staining. Secondary anti-
bodies used were a goat anti-mouse IgG conjugated to
conjugated to Alexa-546 (1:600; InVitrogen; emission
wavelength, 570 nm) and a goat anti-rabbit IgG conju-
gated to Alexa-488 (1:800; InVitrogen; emission wave-
length, 520 nm). In post-MI and diabetic post-MI rats,
neurofilament-M/nestin and GAP43/nestin fibre densities
(μm2; area occupied by the fluorescent signal; LSM image
Browser) were assessed in the peri-infarct and infarct
regions. The fluorescent signal (μm2) was normalized to
the peri-infarct/infarct area (mm2) and calculated as the
average of at least 4 distinct fields. We have published
several papers employing the latter approach to assess
neurofilament-M and nestin fibre density in the adult
rat heart [9,12]. Neurofilament-M/nestin and GAP43/
nestin fibre densities in sham and diabetic rats treated
with 6-hydroxydopamine were measured exclusively in
the left ventricle whereas fibres residing at the epicar-
dium were not considered. Non-specific staining was
determined following the addition of an isotype control
antibody or the conjugated secondary antibody alone.
Immunofluorescence was visualized with a 10×- or
63×-oil 1.4 NA DIC.Statistics
Data are presented as the mean ± S.E.M, and (n) repre-
sents the number of rats used per experiment. Cardiac
morphology, contractile function, immunofluorescence,
plasma glucose and protein data were evaluated by a
one-way ANOVA (GraphPad InStat) and a significant
difference determined by the Student-Newman-Keuls
Multiple Comparisons post-hoc test. Scar weight and
surface area were evaluated by a student’s unpaired
t-test and a value of P < 0.05 considered statistically
significant.Results
Neurofilament-M and GAP43 immunoreactivity of nestin(+)
fibres innervating the scar of infarcted rat hearts
The normal adult Sprague–Dawley rat heart contains
nestin(+) cells intercalated among ventricular myocytes
and neurofilament-M immunoreactive fibres innervating
the myocardium (Figure 1A & B). The co-expression of
the intermediate filament proteins neurofilament-M and
nestin was not observed in the normal adult rat heart.
Twenty-four hours following permanent coronary artery
ligation of the adult heart, the ischemic region was ap-
parent and innervated by nestin(+) fibres. However, the
co-expression of neurofilament-M in nestin(+) fibres in-
nervating the ischemic region of 1-day post-MI rats was
not detected. By contrast, in the peri-infarct/infarct re-
gion of 4 day post-MI rat hearts, innervating nestin(+)
fibres co-expressing neurofilament-M were observed and
neurofilament-M/nestin(+) fibres persisted in the ischemic
region of 7-day post-MI rat hearts (Figure 1C, D & E).
GAP43-immunoreactive fibres were detected in the sham
heart and a paucity of fibres co-expressed the intermediate
filament protein nestin (Figure 1F & G). Twenty-four
hours following complete coronary artery ligation of the
adult rat heart, innervating GAP43- and nestin co-expressing
immunoreactive fibres were observed (Figure 1H, I & J) and
persisted in the peri-infarct/infarct region of 4 day post-MI
rats. In the peri-infarct/infarct region of 7 day post-MI
rat hearts, the appearance of GAP43/nestin(+) fibres was
markedly reduced. A quantitative analysis revealed that
a population of neurofilament-M/nestin(+) fibres were
detected innervating the peri-infarct/infarct region of
4-day post-MI rats and a further significant increase in
density was observed in 7-day post-MI rats (Figure 1K).
By contrast, the density GAP43/nestin(+) fibres in-
nervating the peri-infarct/infarct region was increased
in 1-day post-MI rats and remained significantly ele-
vated in 4-day post-MI rats (Figure 1K) as compared to
sham rats. In 7-day post-MI rats, the density of GAP43/
nestin(+) fibres innervating the peri-infarct/infarct region
rats had returned to levels observed in the sham heart
(Figure 1K).
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Figure 1 Neurofilament-M and GAP43 expression by nestin(+) cells in the heart of sham and 1 week post-MI rat hearts. (Panels A & B) In the left
ventricle of sham rats, neurofilament-M(+) (green fluorescence) and nestin(+) (red fluorescence) fibres were detected and co-expression of the
intermediate filament proteins was not observed. (Panels C, D & E) In the peri-infarct/infarct region of a 4-day post-MI rat heart, innervating
neurofilament-M(+) fibres were detected and the preponderance physically associated with nestin(+) fibres (indicated by arrow). Neurofilament-M(+)
fibres lacking nestin co-expression were also identified (indicated by arrowhead). (Panels F & G) GAP43(+) (green fluorescence) and nestin(+) (red
fluorescence) fibres were detected in the normal rat heart and a paucity co-expressed both proteins. (Panels H, I & J) GAP43/nestin(+) co-
expressing fibres (indicated by arrow) were detected innervating the peri-infarct/infarct region 24 hrs after complete coronary artery ligation.
The nucleus was identified with TO-PRO-3 staining (blue fluorescence). (Panel K) The density of GAP43/nestin(+) fibres innervating the peri-
infarct/infarct region was increased 24 hrs after myocardial infarction and preceded the appearance of neurofilament-M in nestin(+) cells. With
ongoing scar formation/healing, the density of GAP43/nestin(+) fibres progressively decreased whereas a concomitant increase in
neurofilament-M/nestin(+) fibre density was apparent 4 and 7 days after myocardial infarction. (*) denotes P < 0.05 versus sham, (**) P < 0.05
versus 4 day infarcted rat hearts and (ND) not detected.
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the scar in post-myocardial infarcted rats
Experimental type 1 diabetes was induced in adult
male Sprague–Dawley rats following a single injection
of streptozotocin (STZ; 60 mg/kg). One week later, the
heart of type I diabetic rats (n = 23) underwent per-
manent coronary artery ligation. Within 24–48 hrs of
coronary artery ligation, 70% (16/23 rats) of type I dia-
betic rats died. One week after surgery, 22% (5/23) of
the surviving type I diabetic rats that underwent sur-
gery did not have an infarct. Only 8% (2/23 rats) of
type I diabetic rats that underwent permanent coronary
artery ligation had an identifiable scar. No deaths were
observed in sham rats injected with streptozotocin
suggesting that the high mortality rate observed after
coronary artery ligation was directly attributed to myo-
cardial infarction. Unfortunately, the high mortality rate
of type I diabetic rats after permanent coronary artery
ligation precluded further continuation of experimental
protocol. Therefore, as a proof of concept, type I dia-
betes was induced in 3-day post-MI rats. The 3-day
post-MI time point was chosen as the appearance of
neurofilament-M/nestin(+) fibres was at an incipient
stage during the acute phase of scar formation/healing
(Figure 1K). In the MI group, 25% (6/24 rats) died
within 24-48 hrs after coronary artery ligation. Interest-
ingly, no deaths were observed 7 days after streptozotocin
injection of 3-day post-MI rats despite the induction of a
comparable hyperglycaemic environment as observed in
diabetic rats that underwent coronary artery ligation. Left
ventricular contractile function was significantly depressed
in post-MI rats and diabetic rats as compared to sham rats
(Table 1). Seven days following streptozotocin injection
of 3-day post-MI rats, mean arterial pressure and left
ventricular contractile indices were further decreased as
compared to post-MI rats (Table 1). Despite the super-
imposition of type I diabetes to 3-day post-MI rats, scar
weight and surface area were not significantly different
as compared to post-MI rats (Table 1).
In the non-infarcted left ventricle of post-MI rats,
nestin protein expression was significantly increased as
compared to sham rats (Figure 2A & C). In the leftTable 1 Body weight, heart weight and hemodynamic param











sham (n = 8) 350 ± 19 1.13 ± 0.05 126 ± 4 147 ± 5 68
STZ (n = 7) 315 ± 6 1.08 ± 0.06 88 ± 3* 112 ± 5* 6
MI (n = 7-8) 335 ± 8 1.14 ± 0.08 108 ± 3* 134 ± 5 5
MI + STZ (n = 8-12) 266 ± 8*** 0.932 ± 0.05*** 81 ± 3** 97 ± 2*** 46
MI indicates myocardial infarction; MAP, mean arterial pressure; LVSP, left ventricula
rate of left ventricular relaxation. Data are presented as mean ± S.E.M, evaluated by
test, (*) represents P < 0.05 versus sham, (**) represents P < 0.05 versus sham and Mventricle of diabetic rats, nestin protein levels were
markedly reduced as compared to sham rats (Figure 2A
& C). In the non-infarcted left ventricle of diabetic post-
MI rats, nestin protein levels were modestly increased as
compared to diabetic rats but did not reach statistical sig-
nificance. However, nestin protein levels in the non-
infarcted left ventricle of diabetic post-MI rats remained
significantly lower compared to post-MI rats (Figure 2A &
C). Nestin protein content (normalized to GAPDH) was
also reduced in the infarct region of diabetic post-MI rats
(0.47 ± 0.11; n = 8; P < 0.05 versus non-diabetic post-MI
rats) as compared to post-MI rats (0.83 ± 0.10; n = 6). By
contrast, GAP43 protein levels in the heart of sham,
diabetic, post-MI and diabetic post-MI rats were compar-
able (Figure 2A & C). Likewise, GAP43 protein expression
in the scar of diabetic post-MI rats was similar to post-MI
rats (Figure 2B).
In the heart of 10-day post-MI rats, the reparative fi-
brotic response was associated with neurofilament-M(+)
fibres (754 ± 126 μm2/mm2; n = 3) innervating the peri-
infarct/infarct region and the majority co-expressed
nestin (608 ± 79 μm2/mm2; n = 3) (Figure 3A, 3B & 3C).
In the heart of diabetic post-MI rats (Figure 3D, E & F),
the density of neurofilament-M(+) (244 ± 96 μm2/mm2;
n = 3; P < 0.05 versus MI rats) and neurofilament-M/
nestin(+) fibres (71 ± 34 μm2/mm2; n = 3; P < 0.01 versus
MI rats) innervating the peri-infarct/infarct region were
significantly reduced as compared to post-MI rats. The
residual expression of the intermediate filament pro-
tein in the infarct region of diabetic post-MI rats was
attributed at least in part to the continued appearance
of nestin(+) cells with distinct processes and nestin(+)
cardiomyocyte-like cells (Figure 3E).
The impact of type I diabetes on neural remodelling of
the heart following 6-hydroxydopamine administration
The present study has demonstrated that the superim-
position of type I diabetes on MI rats attenuated the
neurogenic response of nestin(+) cells during reparative
fibrosis. To complement and further support these data,
additional experiments were performed to test the hy-
pothesis that a prevailing type I diabetic environmenteters of sham, streptozotocin-treated (STZ), myocardial











59 ± 2241 5832 ± 258 - - 7 ± 1
106 ± 322* 4144 ± 323* - - 33 ± 1*
762 ± 172* 4392 ± 280* 0.055 ± 0.008 0.678 ± 0.11 8 ± 2
58 ± 115*** 2935 ± 103*** 0.058 ± 0.004 0.754 ± 0.06 29 ± 1*
r systolic pressure; LV + dP/dt, rate of left ventricular contraction; LV -dP/dt,
a Student’s unpaired t-test or a Newman-Keuls Multiple Comparisons post-hoc
I, (***) versus sham, MI and STZ and (n) number of rats examined.


























Figure 2 Nestin and GAP43 protein expression in non-diabetic
and diabetic infarcted rat hearts. (Panel A). Nestin expression was
increased in the non-infarcted left ventricle of myocardial infarcted (MI)
rats. In streptozotocin (STZ) induced diabetic rats, nestin protein
expression was diminished as compared to sham rats. Ventricular
nestin protein levels remained reduced following the superimposition
of type I diabetes on 3-day post-MI rats (MI + STZ) as compared to
post-MI rats. Ventricular GAP43 protein levels were comparable in
sham, diabetic, post-MI and diabetic post-MI rats. (Panel B) GAP43
expression was similar in the scar of myocardial infarcted (MI) and
diabetic post-MI rats (MI + STZ). (Panel C) Semi-quantitative assessment
of nestin and GAP43 expression in the left ventricle of sham (n = 4-5)
and diabetic rats (STZ; n = 4) and the non-infarcted left ventricle of
post-MI (MI; n = 4) and diabetic post-MI rats (MI + STZ; n = 6). Data
was normalized to GAPDH protein expression, (*) denotes P < 0.05
versus sham and (**) P < 0.05 versus MI.
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nestin(+) cells to a neuronal-like phenotype in response
to a neurogenic stimulus. Work from our lab has been
previously demonstrated that 6-hydroxydopamine ad-
ministration to normal adult rats promoted the de novo
synthesis of neurofilament-M by cardiac nestin(+) cells
[9,12]. In this regard, 6-hydroxydopamine was adminis-
tered to streptozotocin-injected rats with established
hyperglycaemia. Type I diabetic rats were injected daily
for a period of 3 days with 6-hydroxydopamine and
sacrificed 2 days later. In 6-hydroxydopamine-treated
rats (n = 4; plasma glucose = 7.9 ± 0.1 mM), GAP43/
nestin(+) and neurofilament-M/nestin(+) fibres (Figure 4A,
B & C) were detected innervating the left ventricle.
Following 6-hydroxydopamine administration of type I
diabetic rats (n = 5; plasma glucose = 26 ± 3.9 mM),GAP43/nestin(+) fibres innervating the left ventricle persisted
whereas neurofilament-M/nestin(+) fibres (Figure 4D, E & F)
were less apparent. A quantitative analysis revealed that
the density of GAP43/nestin(+) fibres in the heart of 6-
hydroxydopamine-treated rats was increased as compared
to sham rats and remained significantly elevated following
6-hydroxydopamine administration of type I diabetic rats
(Figure 4G). The density of neurofilament-M/nestin(+)
fibres in the heart of 6-hydroxydopamine-treated rats
was also significantly increased as compared to sham
rats (Figure 4G). By contrast, a significant reduction in
the density of neurofilament-M/nestin(+) fibres innervating
the myocardium was observed in 6-hydroxydopamine-treated
type I diabetic rats as compared to 6-hydroxydopamine-
treated rats (Figure 4G).
Discussion
The rodent heart contains resident nestin(+) cells that
exhibit properties of a neural progenitor/stem cell
population [9,11-15]. Consistent with this premise, the
plating of cardiac-derived nestin(+) cells in a defined in-
duction milieu revealed that a subpopulation differenti-
ated to a neuronal phenotype characterized by the loss
of nestin expression and concomitant upregulation of
neurofilament-M and beta III-tubulin [12]. The in vitro
findings were reproduced in vivo as the de novo synthe-
sis of neurofilament-M by a subpopulation of cardiac
resident nestin(+) cells and subsequent physical associ-
ation of the intermediate filament proteins represents a
seminal event of reparative fibrosis following ischemic
injury of the adult rat heart [9,12].
Transient upregulation of GAP43 by cardiac nestin(+) cells
during reparative fibrosis
Previous studies have identified growth associated pro-
tein 43 (GAP43) as an early and important mediator of
neurogenesis in development and learning and increased
expression was reported during the regeneration of in-
jured peripheral nerves [16-19]. In vitro studies have fur-
ther revealed that skin-derived cells downregulate nestin
and concomitantly express GAP43 during a transition
from a proliferative precursor to a neuronal phenotype
[13]. Despite these findings, the expression and temporal
pattern of GAP43 regulation during the transition of a
neural progenitor/stem cell population to a neuronal
phenotype during wound healing remains unexamined.
Therefore, the present study tested the hypothesis that
the de novo synthesis of neurofilament-M by a subpopu-
lation of cardiac resident nestin(+) cells during the early
phase of reparative fibrosis was preceded by the transient
upregulation of GAP43. In the normal adult rat heart, a
paucity of GAP43(+) fibres innervating the left ventricle
co-expressed the intermediate filament protein nestin.
Twenty-fours hours after complete coronary artery ligation,
A B C
D E F
Figure 3 The impact of type I diabetes on the neurogenic response of cardiac resident nestin(+) cells during scar formation/healing of
the myocardial infarcted rat heart. (Panels A, B & C) Neurofilament-M(+) (green fluorescence) and nestin(+) (red fluorescence) fibres were
detected innervating the peri-infarct/infarct region of a post-MI rat heart and co-expression was evident by the emergence of a yellow
fluorescence (indicated by arrow). Neurofilament-M(+) fibres lacking nestin co-expression were also identified (indicated by arrowhead).
(Panels D, E & F) The reparative fibrotic response of diabetic post-MI rats was associated with a paucity of innervating neurofilament-M/nestin(+) fibres
(indicated by arrow) in the peri-infarct/infarct region. Nestin(+) cardiac myocyte-like cells were detected bordering the scar region and residual nestin(+)
cells and fibres were identified in the peri-infarct/infarct region.
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peri-infarct/infarct region of the ischemically damaged
rat heart, remained elevated in 4 days post-MI rats and
gradually returned to levels observed in sham rats 7 days
after myocardial infarction. By contrast, the co-expression
of nestin and neurofilament-M was not detected in the
peri-infarct/infarct region of 1-day post-MI rats. However,
with ongoing scar formation/healing, the temporal de-
crease of GAP43/nestin(+) fibre density was associated
with a concomitant increase in the density of innervat-
ing neurofilament-M/nestin(+) fibres. Collectively, these
data have demonstrated that GAP43 was upregulated incardiac resident nestin(+) cells prior to the de novo syn-
thesis of neurofilament-M during wound healing of the
ischemically damaged rat heart. The transient induction
of GAP43 during the reparative fibrotic response appar-
ently represents an intermediate event implicated in the
transition of a subpopulation of cardiac nestin(+) cells to
a neuronal-like phenotype.
High mortality rate of type I diabetic rats was observed
following myocardial infarction
Numerous studies have identified a proliferative role of

































Figure 4 The impact of type I diabetes on the neurogenic
response of cardiac resident nestin(+) cells following
administration of 6-hydroxydopamine. (Panels A, B & C) Sham rats
treated with 6-hydroxydopamine promoted the de novo synthesis of
neurofilament-M (green fluorescence) by cardiac resident nestin(+)
(red fluorescence) cells and the intermediate filament proteins were
physically associated as reflected by the emergence of a yellow
fluorescence (indicated by arrow). (Panels D, E, & F) In type I
diabetic rats, the de novo synthesis of neurofilament-M (green
fluorescence) by cardiac resident nestin(+) cells (red fluorescence)
was attenuated in response to 6-hydroxydopamine. The nucleus was
identified with TO-PRO-3 staining (blue fluorescence). (Panel G) The
administration of 6-hydroxydopamine (DOPA) significantly increased
the density of GAP43/nestin(+) and neurofilament-M/nestin(+) fibres in
the heart of sham rats. In the left ventricle of type 1 diabetic rats
treated with 6-hydroxydopamine (Type I + DOPA), the density of
GAP43/nestin(+) fibres remained elevated as compared to sham rats
treated with 6-hydroxydopamine. By contrast, the de novo synthesis of
neurofilament-M was partially inhibited as reflected by the significant
reduction of neurofilament-M/nestin(+) fibre density in the heart of
type I diabetic rats treated with 6-hydroxydopamine. (*) denotes
P < 0.05 versus normal, (**) P < 0.05 versus 6-hydroxydopamine-
treated normal rats (DOPA) and (ND) not detected.
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additional biological function was identified during axonal
sprouting in skeletal muscle. Following muscle injury or in
response to a constitutively active neuregulin receptor,
newly formed nestin(+) fibres were expressed by Schwann
cells located at the motor endplate and physically associ-
ated with axonal sprouts growing from the nerve terminal
[28,29]. The authors suggested that the emergence of
nestin(+) fibres from Schwann cells may directly support
the growth of nerve sprouts possibly acting as a scaffold
and/or guidance mechanism. As previously reported and
documented in the present study, the reparative fibrotic
response of the ischemically damaged rat heart was as-
sociated with the de novo synthesis of neurofilament-M
by a subpopulation of cardiac resident nestin(+) cells.
Thereafter, newly formed neurofilament-M was physic-
ally associated with nestin(+) fibres and innervated the
peri-infarct/infarct region. Thus, it is tempting to specu-
late that the suppression of nestin could significantly
compromise the neurogenic response of Schwann cells
and/or neural progenitor/stem cells during tissue re-
pair. Impaired wound healing represents an established
pathophysiological feature of diabetes related in part to an
inadequate neurogenic response [23-26]. In the heart of
experimental rat models of type I and II diabetes, nestin
protein levels were significantly reduced and not attrib-
uted to cellular apoptosis [27]. These data suggested that
the downregulation of the intermediate filament protein
in a setting of diabetes may significantly limited the neuro-
genic response of a subpopulation of cardiac resident
nestin(+) cells during reparative fibrosis. To directly exam-
ine the premise, streptozotocin-induced type I diabetic
rats were subjected to complete coronary artery occlusion.
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served 24–48 hrs following permanent coronary artery
ligation of the heart of type 1 diabetic rats. An identical
observation was reported by Luo and colleagues as per-
manent coronary artery ligation of the heart of type 1 dia-
betic mice led to a 2-fold greater increase in mortality
within 3–4 days of surgery as compared to non-diabetic
post-MI mice [22]. In our study, no deaths were reported
in type I diabetic rats supporting that premise that the
superimposition of myocardial infarction was directly re-
sponsible for the high mortality rate. These data and those
reported by Luo and colleagues were consistent with clin-
ical studies indicating that diabetic patients have a higher
mortality rate following acute myocardial infarction
and an increased risk of progression to heart failure
post-infarction as compared to non-diabetic post-MI
patients [20,21].The superimposition of type I diabetes on myocardial
infarcted rats attenuated the neurogenic response of
cardiac nestin(+) cells
The high mortality rate of type I diabetic rats subjected
to permanent coronary artery ligation precluded further
continuation of the experimental model. Nonetheless,
the experimental protocol was adapted and as a proof of
concept, streptozotocin was injected in 3 day post-MI
rats and sacrificed 7 days later. In contrast to that ob-
served following the superimposition of myocardial in-
farction on type I diabetic rats, streptozotocin injection
of 3 day post-MI rats did not lead to any deaths. As
expected, the imposition of type I diabetes on post-MI
rats exacerbated left ventricular dysfunction as compared
to post-MI rats. In type I diabetic post-MI rats, nestin pro-
tein levels of the non-infarcted left ventricle and scar were
significantly reduced as compared to post-MI rats. In
post-MI rats, neurofilament-M(+) fibres were detected
innervating the peri-infarct/infarct region and the pre-
ponderance physically associated with nestin(+) fibres.
In the peri-infarct/infarct region of type I diabetic post-
MI rat hearts, neurofilament-M(+) and neurofilament-
M/nestin(+) fibre densities were significantly reduced.
The inadequate neurogenic response in the scar of type
I diabetic post-MI rats was apparently not secondary to
a downregulation of GAP43 protein levels. Thus, the
reduced neurogenic response in the scar of diabetic
post-MI rats was attributed in part to the inadequate
de novo synthesis of neurofilament-M by a subpopula-
tion of cardiac resident nestin(+) cells. Downregulation
of the intermediate filament protein nestin may repre-
sent in part an underlying mechanism suppressing the
transition of cardiac resident nestin(+) cells to a neuronal-
like phenotype. Moreover, we cannot exclude the possibil-
ity that the prevailing hyperglycaemic environment mayhave further inhibited the synthesis of neurofilament-M
by cardiac nestin(+) cells.
The induction of a type I diabetic environment rather
than a direct effect of streptozotocin attenuated the
neurogenic response of post-MI rats
The uptake of streptozotocin in pancreatic beta cells is
attributed to the presence of the GLUT2 transporter
[30]. Following entry and accumulation in beta cells, the
alkylating action of streptozotocin leads to toxicity, cell
death and subsequent loss of insulin synthesis [30]. By
contrast, insulin-producing cells that do not express
GLUT2 are resistant to the direct pathological action of
streptozotocin [30]. Moreover, organ damage reported in
the kidney and liver following streptozotocin administra-
tion was likewise attributed to the uptake of the drug by
the GLUT2 transporter [30]. Based on these data, the
attenuated neurogenic response of cardiac nestin(+) cells
during reparative fibrosis following the superimposition
of type I diabetes may have been related in part to a direct
effect of streptozotocin. However, the GLUT2 transporter
was not expressed in adult rat brain-derived neural stem
cells whereas GLUT1 and GLUT3 were highly abundant
and the GLUT2 transcript was undetectable in the adult
rodent heart [31,32]. The tissue specific distribution
of GLUT2 was consistent with the disparate level of
radioactive-labeled streptozotocin detected in the liver
and heart following intravenous injection of the adult
male rat [33]. In addition, streptozotocin is a highly
unstable molecule with a reported biological half-life
of ~5 minutes and ~40 minutes in rodents and humans,
respectively [34,35]. Therefore, based on the short half-life
of streptozotocin and apparent absence of GLUT2
transporter expression in the rodent heart as well as
neural progenitor/stem cells, it is highly unlikely that the
compromised neurogenic response of cardiac nestin(+)
cells during reparative fibrosis was related to a direct effect
of streptozotocin that persisted for 7 days.
A type I diabetic environment attenuated the
neurogenic response of cardiac nestin(+) cells following
6-hydroxydopamine administration
To reaffirm that a hyperglycaemic environment rather than a
direct effect of streptozotocin suppressed the neurogenic re-
sponse of cardiac resident nestin(+) cells, 6-hydroxydopamine
was administered to rats with established type I diabetes.
Work from our lab has previously demonstrated that
the treatment of normal adult male rats with 6-
hydroxydopamine led to the degeneration of sympathetic
fibres and concomitantly induced the de novo synthesis of
neurofilament-M by a subpopulation of cardiac resident
nestin(+) cells [9,12]. Therefore, the following experiments
tested the hypothesis that the neurogenic response of
nestin(+) cells to 6-hydroxydopamine was compromised
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6-hydroxydopamine-treated rats, the density of GAP43/
nestin(+) and neurofilament-M/nestin(+) fibres were signifi-
cantly increased as compared to non-treated rats. Seven
days following streptozotocin injection, 6-hydroxydopamine
was administered to type I diabetic rats and the density of
GAP43/nestin(+) fibres in the left ventricle remained signifi-
cantly elevated and quantitatively similar to the response
observed in 6-hydroxydopamine treated rats. By contrast,
the density of neurofilament-M/nestin(+) fibres in the left
ventricle of 6-hydroxydopamine-treated diabetic rats was sig-
nificantly reduced. Thus, in response to 6-hydroxydopamine,
a type I diabetic environment abrogated the transition of
cardiac resident nestin(+) cells to a neuronal-like pheno-
type via the selective suppression of neurofilament-M syn-
thesis. These data complement the paradigm identified in
the heart of 3-day post-MI rats subjected to type I diabetes
and further supports the premise that a diabetic milieu ra-
ther than a direct effect of streptozotocin compromised
the neurogenic response of a subpopulation of cardiac
resident nestin(+) cells.
Conclusion
The temporal disparity of GAP43 and neurofilament-M
expression by cardiac resident nestin(+) cells during scar
formation/healing of the ischemically damaged rat heart
suggests that the prior induction of GAP43 may repre-
sent an essential intermediate event in the transition to a
neuronal-like phenotype. Inadequate wound healing rep-
resents a hallmark feature of diabetes related in part to
an impaired neurogenic response. The present study has
reaffirmed and further expanded on the latter paradigm
as the superimposition or the pre-existence of a type I
diabetic environment abrogated the neurogenic response
of cardiac resident nestin(+) cells to ischemia and 6-
hydroxydopamine, respectively. These findings may not
be limited to the rodent as nestin(+) cells were identified
in the human heart, brain and skin [9,12,36,37]. Moreover,
at least in the human brain and skin, a subpopulation of
nestin(+) cells exhibited properties of a neural progenitor/
stem cell population including neurosphere formation and
differentiation to a neuronal cell [36,37]. In this regard,
the inadequate differentiation of nestin(+) cells to a neur-
onal phenotype may in part contribute to the impaired
neurogenic response reported during wound healing of
injured diabetic tissue.
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